reference/12254806

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/12254806

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
issn	1748-605X
issueIdentifier	6
pageRange	065021-
publicationName	Biomedical materials (Bristol, England)
startingPage	065021
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_ff7cc274fc005f95d2b880b810c0e5d0 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a881bc874cdba44d3dfc1e8abbbeace7 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_2c54a9408779a437ec59c7e82aede69e
bibliographicCitation	Prieto E, Cardiel MJ, Vispe E, Idoipe M, Garcia-Martin E, Fraile JM, Polo V, Mayoral JA, Pablo LE, Rodrigo MJ. Dexamethasone delivery to the ocular posterior segment by sustained-release Laponite formulation. Biomed Mater. 2020 Nov 21;15(6):065021. doi: 10.1088/1748-605x/aba445. PMID: 32647098.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b87a97ff1d715829cc0b2c3eae4487cb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_530f1128c0f8019967e7d7b6362623cd http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-6258-2489 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_777d707e9bfaf9e7031f1d09276b86f9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-4009-3075 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c7da3918dc1e20b2e3d90ba1a4c90aba http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7ff201d2d9542862e70c9de684608ec9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-4921-4734 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_835794f890d69ece6dfd858606de34c4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b7b4a4560cf5f5fe31cc27198baf7e2b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_96d28cf20f27fb335385d540b39f2949
date	2020-11-21^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/32647098 https://doi.org/10.1088/1748-605x/aba445
isPartOf	https://portal.issn.org/resource/ISSN/1748-605X http://rdf.ncbi.nlm.nih.gov/pubchem/journal/34211
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Dexamethasone delivery to the ocular posterior segment by sustained-release Laponite formulation
discusses	http://id.nlm.nih.gov/mesh/M0015329 http://id.nlm.nih.gov/mesh/M0516314 http://id.nlm.nih.gov/mesh/M0006099 http://id.nlm.nih.gov/mesh/M0026710
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D016503 http://id.nlm.nih.gov/mesh/D017640Q000737 http://id.nlm.nih.gov/mesh/D003907Q000008
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D002851 http://id.nlm.nih.gov/mesh/D002853 http://id.nlm.nih.gov/mesh/D011817 http://id.nlm.nih.gov/mesh/D009883Q000627 http://id.nlm.nih.gov/mesh/D002829Q000187 http://id.nlm.nih.gov/mesh/D002829Q000737 http://id.nlm.nih.gov/mesh/D012160Q000187 http://id.nlm.nih.gov/mesh/D013058 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D014822 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D005123Q000187
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5743 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7671 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71587168

Showing number of triples: 1 to 52 of 52.